Cargando…

Role of inhaled antibiotics in the era of highly effective CFTR modulators

Recurrent and chronic bacterial infections are common in people with cystic fibrosis (CF) and contribute to lung function decline. Antibiotics are the mainstay in the treatment of exacerbations and chronic bacterial infection in CF. Inhaled antibiotics are effective in treating chronic respiratory b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elborn, J. Stuart, Blasi, Francesco, Burgel, Pierre-Régis, Peckham, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2023
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879329/ https://www.ncbi.nlm.nih.gov/pubmed/36631132 http://dx.doi.org/10.1183/16000617.0154-2022

Ejemplares similares

Editorial: Real-world experience with CFTR modulator therapy
por: Tümmler, Burkhard, et al.
Publicado: (2023)

CFTR Modulators in People with Cystic Fibrosis: Real-World Evidence in France
por: Regard, Lucile, et al.
Publicado: (2022)

The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022)

The gut-lung axis in the CFTR modulator era
por: Lussac-Sorton, Florian, et al.
Publicado: (2023)

Airway Inflammation and Host Responses in the Era of CFTR Modulators
por: Keown, Karen, et al.
Publicado: (2020)

Targeted therapies to improve CFTR function in cystic fibrosis
por: Brodlie, Malcolm, et al.
Publicado: (2015)

The era of CFTR modulators: improvements made and remaining challenges
por: Cuevas-Ocaña, Sara, et al.
Publicado: (2020)

Inhaled Dual Phosphodiesterase 3/4 Inhibitors for the Treatment of Patients with COPD: A Short Review
por: Martin, Clémence, et al.
Publicado: (2021)

The Role of MMPs in the Era of CFTR Modulators: An Additional Target for Cystic Fibrosis Patients?
por: Esposito, Renata, et al.
Publicado: (2023)

Ciprofloxacin dry powder inhaler in cystic fibrosis
por: Elborn, J Stuart
Publicado: (2016)

Establishing Antimicrobial Susceptibility Testing Methods and Clinical Breakpoints for Inhaled Antibiotic Therapy
por: Ekkelenkamp, Miquel B, et al.
Publicado: (2022)

ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies
por: Mall, Marcus A.
Publicado: (2020)

CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
por: Lopes-Pacheco, Miquéias
Publicado: (2020)

14: Pregnancy and outcomes in the era of CFTR modulators and COVID-19 pandemic
por: Li, S., et al.
Publicado: (2021)

Fertility, Pregnancy and Lactation Considerations for Women with CF in the CFTR Modulator Era
por: Jain, Raksha, et al.
Publicado: (2021)

The Exocrine Pancreas in Cystic Fibrosis in the Era of CFTR Modulation: A Mini Review
por: McKay, Isabelle R., et al.
Publicado: (2022)

Revisiting Host-Pathogen Interactions in Cystic Fibrosis Lungs in the Era of CFTR Modulators
por: Ribeiro, Carla M. P., et al.
Publicado: (2023)

TACKLING ANTIMICROBIAL RESISTANCE (AMR) - IN VITRO EFFECT OF SODIUM CHLORIDE ON ANTIBIOTIC SUSCEPTIBILITY IN CLINICAL PSEUDOMONAS AERUGINOSA ISOLATED FROM PATIENTS WITH CYSTIC FIBROSIS (CF)
por: Gramegna, Andrea, et al.
Publicado: (2020)

Different CFTR modulator combinations downregulate inflammation differently in cystic fibrosis
por: Jarosz-Griffiths, Heledd H, et al.
Publicado: (2020)

The Impact of Highly Effective CFTR Modulators on Growth and Nutrition Status
por: Bass, Rosara, et al.
Publicado: (2021)

From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis
por: Gramegna, Andrea, et al.
Publicado: (2020)

Pharmacological Responses of the G542X-CFTR to CFTR Modulators
por: Fang, Xinxiu, et al.
Publicado: (2022)

The role of antibiotics in asthma
por: Blasi, Francesco, et al.
Publicado: (2007)

Of muscle modulation and the CFTR gate
por: Adler, Elizabeth M.
Publicado: (2015)

The PROSPECT Is Bright for CFTR Modulators
por: Montemayor, Kristina, et al.
Publicado: (2021)

188: Cystic fibrosis kidney stone disease in the era of CFTR modulator use and the COVID-19 pandemic
por: Romano, S., et al.
Publicado: (2021)

The impact of SARS-CoV-2 infection in patients with cystic fibrosis undergoing CFTR channel modulators treatment: a literature review
por: Vitiello, Antonio, et al.
Publicado: (2023)

Management of Individual Patient Expectations When Starting with Highly Effective CFTR Modulators
por: Aalbers, Bente L., et al.
Publicado: (2021)

The role of biomarkers in community-acquired pneumonia: predicting mortality and response to adjunctive therapy
por: Mira, Jean-Paul, et al.
Publicado: (2008)

Modulation of CFTR gating by permeant ions
por: Yeh, Han-I, et al.
Publicado: (2015)

Modulator treatment for people with cystic fibrosis: moving in the right direction
por: Elborn, J. Stuart
Publicado: (2020)

Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design
por: Jain, Raksha, et al.
Publicado: (2022)

P111 Forced oscillation techniques – is it useful for the monitoring of adult patients with cystic fibrosis in the era of CFTR modulators
por: Markelić, I., et al.
Publicado: (2023)

Real-life impact of highly effective CFTR modulator therapy in children with cystic fibrosis
por: Olivier, Margarete, et al.
Publicado: (2023)

Role of CFTR in epithelial physiology
por: Saint-Criq, Vinciane, et al.
Publicado: (2016)

Airway Epithelial Inflammation In Vitro Augments the Rescue of Mutant CFTR by Current CFTR Modulator Therapies
por: Gentzsch, Martina, et al.
Publicado: (2021)

The effect of CFTR modulators on structural lung disease in cystic fibrosis
por: Mok, L. Clara, et al.
Publicado: (2023)

Antibiotic resistance in chronic respiratory diseases: from susceptibility testing to the resistome
por: Pailhoriès, Hélène, et al.
Publicado: (2022)

Mucus Plugs in Medium-sized Airways: A Novel Imaging Biomarker for Phenotyping Chronic Obstructive Pulmonary Disease
por: Chassagnon, Guillaume, et al.
Publicado: (2021)

CFTR-regulated MAPK/NF-κB signaling in pulmonary inflammation in thermal inhalation injury
por: Dong, Zhi Wei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2dhqavr5e57prnk7e52p0ica2g